A registry study led by the University of Oulu examined the early-stage treatment of relapsing-remitting multiple sclerosis (MS) in Finland between 2013 and 2022.

Spasticity in multiple sclerosis was the most common condition cited by the doctors for treatment with medical cannabis, ...

"A tooth infection can kill you, but rarely," warns a Cleveland Clinic expert. Here's how to recognize the risks and how it ...

MOBOs founder Kanya King reduced the audience to tears as she made a speech at the 2025 music awards ceremony after revealing ...

The primary primary cancer – which had already spread throughout her skeleton and also to her brain – was later revealed to ...

Love Island star Shaughna Phillips has spoken about her experience with the condition that can leave sufferers ashamed and ...

A screening tool was effective in identifying abuse among young children with a single bruise in a pediatric emergency ...

In recent years many viewers have accused the national broadcaster of falling prey to obsessive political correctness and ...

A sponge-like implant in mice helped guide a treatment that slowed or stopped a degenerative condition similar to multiple sclerosis in humans. It also gave University of Michigan researchers a first ...

Measles, one of the world’s most contagious infectious diseases, can cause serious complications – such as blindness, ...

Researchers from Bonn and Erlangen identify the protein MLC1 as a target antigen in multiple sclerosis (MS); a chronic ...